Navigation Links
Neogen launches comprehensive cattle genomic test
Date:5/6/2013

LANSING, Mich., May 6, 2013 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today the development of a new genomic test that offers the beef cattle industry an unprecedented level of information on the genetic potential of individual animals.

Neogen's new GeneSeek® Genomic Profiler™ (GGP-HD) contributes comprehensive data included in Angus genomic-enhanced expected progeny differences (GE-EPDs), which reveal an animal's genetic potential well before breeding, as well as the animal's parentage, and important genetic trait and disease information on the animal. With Angus Genetics Inc. (AGI), Neogen recently announced the availability of a breed-specific version of the new product, the GeneSeek Angus GGP-HD.

"This new test solidifies Neogen's position as the leading provider of genetic testing to the cattle industry," said James Herbert , Neogen's CEO and chairman. "Especially now with the recent changes in the cattle industry, decisions ranchers make on individual animals can be critical to maximizing that ranch's profitability. With this one test, a rancher can decide if the heifer has the genetic merit to keep on the ranch, and exclude the animals that would make poor choices for breeding, or would develop a genetic condition that would reduce its value."

Results from the advanced GeneSeek Angus GGP-HD test will be incorporated into Angus GE-EPDs, which are available on a weekly basis through the American Angus Association National Cattle Evaluation. In 2009, AGI, in collaboration with Neogen's Igenity subsidiary, provided the beef industry with Angus-specific GE-EPDs. Since that time, AGI has continued to foster the research and implementation strategy with GeneSeek to continue to bring high-quality genomic tests into the weekly EPD updates used by Angus breeders and their customers.

The GeneSeek GGP-HD technology is an improvement on the well-known Igenity Profile for Angus test. The custom, high density chip features a unique new design that features nearly 78,000 single nucleotide polymorphisms (SNPs) selectively chosen from studies on thousands of animals. The test provides parentage information at no extra charge. Specialty add-on tests will be available for a number of genetic conditions at minimal additional cost.  

As another product offering, Neogen offers beef cattlemen a beef heifer replacement test for breeds other than Angus, including trait detection for Bos indicus-influenced females. The company also offers the beef industry a comprehensive line of animal health products, including veterinary instruments, uniquely detectable D3 needles, and disinfectants, cleaners and rodenticides to enhance a ranch's biosecurity.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics, along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

AGI is a division of the American Angus Association , with headquarters in Saint Joseph, Mo., which offers services to the more than 30,000 members of the American Angus Association and thousands of commercial cattle producers using Angus genetics across the United States.

CONTACT: Dr. Stewart Bauck , Neogen Corporation
402/435-0665, sbauck@neogen.com

 


'/>"/>
SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen reports 27% increase in quarterly net income
2. Neogen launches rapid tests for ractopamine
3. Neogen Corporation Announces 3rd Quarter Results Conference Call
4. Neogen reports 30% increase in quarterly net income
5. Neogen Corporation Announces 1st Quarter Results Conference Call
6. Neogen reports year end results
7. Neogen Corporation Announces Year-End Results Conference Call
8. Neogen acquires Igenity from Merial
9. Neogen launches the fastest molecular pathogen test
10. Neogen Launches Fully Quantitative Lateral Flow Test for DON
11. Neogen Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... HILL, N.C. , Feb. 5, 2016  In ... key role for a host of launch activities including ... importance of this launch activity is especially high in ... specialists. Best Practices and the Role of ... will help companies focused on oncology therapies find better ...
(Date:2/4/2016)... Massachusetts , February 4, 2016 - New FDA ... - New FDA action date of July 22, ... of July 22, 2016   - ... U.S. in the past decade indicated for the treatment of signs and symptoms ... Lifitegrast has the potential to be the only product approved in the U.S. ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):